Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
Nadeem R. Abu‐Rustum, Catheryn M. Yashar, Rebecca C. Arend, et al.
Journal of the National Comprehensive Cancer Network (2023) Vol. 21, Iss. 2, pp. 181-209
Closed Access | Times Cited: 337

Showing 1-25 of 337 citing articles:

18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients
Claudio Spick, Ken Herrmann, Johannes Czernin
Journal of Nuclear Medicine (2016) Vol. 57, Iss. 3, pp. 420-430
Open Access | Times Cited: 168
FIGO 2023 endometrial cancer staging: too much, too soon?
W. Glenn McCluggage, Tjalling Bosse, C. Blake Gilks, et al.
International Journal of Gynecological Cancer (2023) Vol. 34, Iss. 1, pp. 138-143
Open Access | Times Cited: 40
Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes
Ilaria Cuccu, Francesco Raspagliesi, Mario Malzoni, et al.
European Journal of Surgical Oncology (2024) Vol. 50, Iss. 4, pp. 108018-108018
Closed Access | Times Cited: 18
Role of MRI in Assessing the Feasibility of Fertility-Sparing Treatments for Early-Stage Endometrial and Cervical Cancers
Mihan Lee, P Andrieu, Stéphanie Nougaret, et al.
American Journal of Roentgenology (2025), pp. 1-16
Closed Access | Times Cited: 2
Case report: A case of type 1 diabetes with diabetic ketoacidosis induced by envafolimab treatment in hepatocellular carcinoma
Youjia Li, Kai Qu, Xiuli Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device
Navdeep Pal, Russell R. Broaddus, Diana L. Urbauer, et al.
Obstetrics and Gynecology (2017) Vol. 131, Iss. 1, pp. 109-116
Open Access | Times Cited: 167
Sentinel node mapping in endometrial cancer
Giorgio Bogani, Andrea Giannini, Enrico Vizza, et al.
Journal of Gynecologic Oncology (2023) Vol. 35, Iss. 1
Open Access | Times Cited: 25
Molecular Targeting of the Human Epidermal Growth Factor Receptor-2 (HER2) Genes across Various Cancers
Elizabeth S. Rubin, Khine Shan, Shivani Dalal, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1064-1064
Open Access | Times Cited: 14
Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection
Natalia Galant, Paweł Krawczyk, Marta Monist, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5893-5893
Open Access | Times Cited: 13
Efficacy and Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer
Alessandro D. Santin, Bradley R. Corr, Alexander I. Spira, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 29, pp. 3421-3429
Closed Access | Times Cited: 12
2023 FIGO staging system for endometrial cancer: The evolution of the revolution
David K. Gaffney, Xavier Matías‐Guiu, David G. Mutch, et al.
Gynecologic Oncology (2024) Vol. 184, pp. 245-253
Closed Access | Times Cited: 11
Oncologic outcomes based on lymphovascular space invasion in node-negative FIGO 2009 stage I endometrioid endometrial adenocarcinoma: a multicenter retrospective cohort study
Christian Dagher, Pernille Bjerre Trent, Rofieda Alwaqfi, et al.
International Journal of Gynecological Cancer (2024) Vol. 34, Iss. 10, pp. 1485-1492
Closed Access | Times Cited: 11
Recent Therapeutic Advances in Gynecologic Oncology: A Review
Elise Wilson, Ramez N. Eskander, Pratibha Binder
Cancers (2024) Vol. 16, Iss. 4, pp. 770-770
Open Access | Times Cited: 10
Potential of molecular classification to guide fertility-sparing management among young patients with endometrial cancer
Núria Agustí, Alexa Kanbergs, Roni Nitecki
Gynecologic Oncology (2024) Vol. 185, pp. 121-127
Open Access | Times Cited: 10
Prediction of recurrence risk in endometrial cancer with multimodal deep learning
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, et al.
Nature Medicine (2024) Vol. 30, Iss. 7, pp. 1962-1973
Open Access | Times Cited: 10
Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies
Fernando O. Recio, Carly Bess Scalise, Paul Loar, et al.
Gynecologic Oncology (2024) Vol. 182, pp. 63-69
Open Access | Times Cited: 9
Disparities in medical recommendations from AI-based chatbots across different countries/regions
Khanisyah E. Gumilar, Birama Robby Indraprasta, Yu-Cheng Hsu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Effect of Substantial Lymphovascular Space Invasion on Location of First Disease Recurrence in Surgical Stage I Endometrioid Endometrial Adenocarcinoma
Christian Dagher, Pernille Bjerre Trent, Rofieda Alwaqfi, et al.
International Journal of Gynecological Cancer (2025), pp. 101651-101651
Closed Access | Times Cited: 1
Impaired function of dendritic cells within the tumor microenvironment
Zhihua Xiao, Ruiqi Wang, Xuyan Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Lymphovascular Space Invasion in Early-Stage Endometrial Cancer (LySEC): Patterns of Recurrence and Predictors. A Multicentre Retrospective Cohort Study of the Spain Gynecologic Oncology Group
Reyes Oliver Peréz, Pablo Padilla-Iserte, Octavio Arencibia, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2612-2612
Open Access | Times Cited: 17
Explainable machine learning model for predicting skeletal muscle loss during surgery and adjuvant chemotherapy in ovarian cancer
Wen‐Han Hsu, A.-R. Ko, Chia‐Sui Weng, et al.
Journal of Cachexia Sarcopenia and Muscle (2023) Vol. 14, Iss. 5, pp. 2044-2053
Open Access | Times Cited: 16
Assessment of sentinel Lymph node mapping with different volumes of Indocyanine green in early-stage ENdometrial cancer: the ALIEN study
Jessica Mauro, Diego Raimondo, Giampaolo Di Martino, et al.
International Journal of Gynecological Cancer (2024), pp. ijgc-005100
Closed Access | Times Cited: 7
Translating biological insights into improved management of endometrial cancer
Jeffrey How, Amir A. Jazaeri, Shannon N. Westin, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 11, pp. 781-800
Closed Access | Times Cited: 6
Molecular image–guided surgery in gynaecological cancer: where do we stand?
Giusi Pisano, Thomas Wendler, Renato A. Valdés Olmos, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 10, pp. 3026-3039
Open Access | Times Cited: 5
Lower limb lymphedema after surgical staging for endometrial cancer: Current insights and future directions
Giuseppe Cucinella, Mariano Catello Di Donna, Jvan Casarin, et al.
Taiwanese Journal of Obstetrics and Gynecology (2024) Vol. 63, Iss. 4, pp. 500-505
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top